Search Results - "López, José Ramón Arribas"

A Randomized Phase 3 Study Comparing Once-Daily Elvitegravir With Twice-Daily Raltegravir in Treatment-Experienced Subjects With HIV-1 infection: 96-Week Results by Elion, Richard, Molina, Jean-Michel, Ramón Arribas López, José, Cooper, David, Maggiolo, Franco, Wilkins, Edmund, Conway, Brian, Liu, Ya-Pei, Margot, Nicolas, Rhee, Martin, Chuck, Steven L, Szwarcberg, Javier

“…This 96-week, double-blind, active-controlled, phase 3 study, randomized subjects to elvitegravir once daily or raltegravir twice daily with a fully active,…”
Get full text

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial by Spinner, Christoph D, Gottlieb, Robert L, Criner, Gerard J, Arribas López, José Ramón, Cattelan, Anna Maria, Soriano Viladomiu, Alex, Ogbuagu, Onyema, Malhotra, Prashant, Mullane, Kathleen M, Castagna, Antonella, Chai, Louis Yi Ann, Roestenberg, Meta, Tsang, Owen Tak Yin, Bernasconi, Enos, Le Turnier, Paul, Chang, Shan-Chwen, SenGupta, Devi, Hyland, Robert H, Osinusi, Anu O, Cao, Huyen, Blair, Christiana, Wang, Hongyuan, Gaggar, Anuj, Brainard, Diana M, McPhail, Mark J, Bhagani, Sanjay, Ahn, Mi Young, Sanyal, Arun J, Huhn, Gregory, Marty, Francisco M

“…IMPORTANCE: Remdesivir demonstrated clinical benefit in a placebo-controlled trial in patients with severe coronavirus disease 2019 (COVID-19), but its effect…”
Get full text

Impact and characteristics of hospital-acquired influenza over 10 seasons in a third-level university hospital by Mangas-Moro, Alberto, Zamarrón-de-Lucas, Ester, Carpio-Segura, Carlos Javier, Álvarez-Sala-Walther, Rodolfo, Arribas-López, José Ramón, Prados-Sánchez, Concepción

“…To analyze the characteristics of patients with nosocomial flu, to compare them with patients with community-acquired influenza to study possible differences…”
Get full text

Impact of virulence genes on sepsis severity and survival in Escherichia coli bacteremia by Mora-Rillo, Marta, Fernández-Romero, Natalia, Navarro-San Francisco, Carolina, Díez-Sebastián, Jesús, Romero-Gómez, Maria Pilar, Arnalich Fernández, Francisco, Arribas López, Jose Ramon, Mingorance, Jesús

“…Extraintestinal pathogenic Escherichia coli (ExPEC) are a frequent cause of bacteremia and sepsis, but the role of ExPEC genetic virulence factors (VFs) in…”
Get full text

Impacto y características de la gripe nosocomial a lo largo de 10 temporadas en un hospital universitario de tercer nivel by Mangas-Moro, Alberto, Zamarrón-de-Lucas, Ester, Carpio-Segura, Carlos Javier, Álvarez-Sala-Walther, Rodolfo, Arribas-López, José Ramón, Prados-Sánchez, Concepción

“…Analizar las características de los pacientes con gripe nosocomial, compararlas con las de los enfermos con diagnóstico de gripe comunitaria para estudiar…”
Get full text

Endothelial function in HIV-infected patients with low or mild cardiovascular risk by Blanco, Juan José Ríos, García, Inés Suárez, Cerezo, Jorge Gómez, de Rivera, José María Peña Sánchez, Anaya, Pilar Moreno, Raya, Pilar García, García, Juan González, López, José Ramón Arribas, Hernández, Francisco Javier Barbado, Rodríguez, Juan José Vázquez

“…Background: Highly active antiretroviral therapy for HIV-infected patients is associated with metabolic side effects, which could cause an increased…”
Get full text

Controversies and future of the approach to cardiovascular disease in HIV patients by Bernardino de la Serna, José Ignacio, Arribas López, José Ramón

“…Cardiovascular diseases are an increasing problem in patients with HIV infection. The causes of the increased cardiovascular risk in HIV-infected patients are…”
Get full text

Prospective validation of a pharmacogenetic test: the PREDICT-1 study by Muñoz de Benito, Rosa M, Arribas López, José Ramón

“…The aim of the PREDICT-1 study was to determine the clinical utility of the pharmacogenetic test identifying HLA-B*5701 to reduce the incidence of…”
Get full text

Implementation of a centralized pharmacovigilance system in academic pan‐European clinical trials: Experience from EU‐Response and conect4children consortia by Terzić, Vida, Figarella, Mélanie, Mercier, Noémie, De Gastines, Lucie, Gibowski, Séverine, Trøseid, Marius, Demotes, Jacques, Olsen, Inge Christoffer, Hites, Maya, Ader, Florence, Lopez, José Ramón Arribas, Mentré, France, Espérou, Hélène, Røttingen, John‐Arne, Poissy, Julien, Rozé, Jean‐Christophe, Warris, Adilia, O'Leary, Jackie, Fernandes, Ricardo M., Assoumou, Lambert, Hankard, Regis, Turner, Mark A., Yazdanpanah, Yazdan, Diallo, Alpha, Trøseid, Marius, Holten, Aleksander Rygh, Barratt‐Due, Andreas, Olsen, Inge Christoffer, Westerheim, Elin, Colban, Martha, Tonby, Kristian, Poissy, Julien, Peiffer‐Smadja, Nathan, Eustace, Joe, Keane, Ruben E., Arribàs, José R., Garcia, Irene, Mazzaferri, Fulvia, Hites, Maya, Grimaldi, David, Reuter, Jean, Staub, Therese, Berchem, Guy, Delmas, Christelle, Fougerou‐Leurent, Claire, Ferrane, Assia, Beniguel, Lydie, Baldé, Aliou, Costagliola, Dominique, Belhadi, Drifa, Dechanet, Aline, Del Alamo, Marta, Ader, Florence, Luz, Filipa, Greil, Richard, Keuschnig, Alexandra, Hajdu, Edit, Halanova, Monika, Troníčková, Radka, Trojanek, Milan, Nerušilová, Katerina, Piekarska, Anna, Wiesner, Agnieszka, Bano, Jesus, Tsiodras, Sotirios, Ladenstein, Ruth, Johan, Vande Walle, Degraeuwe, Eva, Kvamme, Anne Mathilde H., Rajasaar, Héli, Papazisis, Georgios, László, Bálint, O'cleary, Jackie, Bigagli, Elisabetta, Ryszard, Sot, Sousa, Catarina, Rodríguez‐Tenreiro, Carmen, Kindblom, Jenny, Ruegger, Christoph, Geest, Tessa, Bruggemann, Roger, Neubert, Antje, Rozé, Jean‐Christophe, Drouard, Anne, Espérou, Hélène, Dumousseaux, Marina, Moal, Anaelle, Michon, Amelie, Bouazza, Naim, Ursino, Moreno, Hervé, Magali, Boussaha, Inesse, Lozano, Helene, Gueyffier, Francois, Dilo, Ana, Negrini, Anna, Di Maggio, Lucia, Rocchi, Francesca, Polikar, Betty, Warris, Adilia

“…Setting‐up a high quality, compliant and efficient pharmacovigilance (PV) system in multi‐country clinical trials can be more challenging for academic sponsors…”
Get full text

Introducción by Pulido Ortega, Federico, López, José Ramón Arribas

Get full text

Lopinavir/ritonavir monotherapy in the treatment of HIV infection. Introduction by Pulido Ortega, Federico, Arribas López, José Ramón

Get full text

Introducción by Pulido Ortega, Federico, López, José Ramón Arribas

Get full text

Introducción by Pulido Ortega, Federico, López, José Ramón Arribas

Get full text

Controversias y futuro del abordaje de la enfermedad cardiovascular en pacientes con VIH by Bernardino De La Serna, José Ignacio, Arribas López, José Ramón

“…Resumen Las enfermedades cardiovasculares son un problema creciente en pacientes infectados por el virus de inmunodeficiencia humana (VIH). El aumento del…”
Get full text

Datos clínicos I. Experiencia clínica de tenofovir en combinaciones con inhibidores no análogos de la transcriptasa inversa by de la Serna, José Ignacio Bernardino, Rillo, Marta Mora, López, José Ramón Arribas

“…La aparición del tratamiento antirretroviral de gran actividad ha supuesto una drástica mejora en el pronóstico de los pacientes infectados por el virus de…”
Get full text

Validación prospectiva de un test farmacogenético: estudio PREDICT-1 by Muñoz de Benito, Rosa M, Arribas López, José Ramón

“…El ensayo PREDICT-1 tuvo como objetivo comprobar la utilidad clínica del test farmacogenético que determina el HLA-B*5701 para reducir la incidencia de…”
Get full text

Retrospective epidemiological study on the durability of the treatment of HIV infection or AIDS in Spain by Arribas López, José Ramón, Sanz Baena, Susana, Hernández Albujar, Susana, Lorenzo Hernández, Alicia, Montes Ramiréz, M Luisa, Palacios Muñoz, Rosario, Márquez Solero, Manuel, Santos González, Jesús, Ocampo Hermida, Antonio, Miralles Alvarez, Celia, López Aldeguer, José, Salavert Lletí, Miguel, Tordera Higón, Pablo, Santamaría Jáuregui, Juan Miguel, Teira Cobo, Ramón M, Moreno Guillén, Santiago, Moreno Zamora, Ana, Gatell Artigas, José M, Mallotas Masferrer, José, Callau Cabrera, Pilar, Gonzáles de Suso, Miguel Torralba, Costa Cerdá, Asunción, Cepeda Gonzáles, Concepción, Pulido Ortega, Federico, Condes Moreno, Emilia, Barros Aguado, Carlos, del Llano Señarís, Juan, Coduras, Alicia, Olivia, Juan, Burgos Ramírez, Angel, González-Lahoz, Juan, Díaz, Beatriz

“…To know the durability of consecutive regimens of antiretroviral treatment is important to design a long-term therapy, but there is not much information about…”
Get more information

Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with lopinavir/ritonavir plus lamivudine for initial ART in HIV infected adults by Gatell Artigas, Josep María, Arribas López, José Ramón, Lázaro y de Mercado, Pablo, Blasco Bravo, Antonio Javier

“…Abstract Introduction The National AIDS Plan and the Spanish AIDS study group (GESIDA) proposes “preferred regimens” (PR) of antiretroviral treatment (ART) as…”
Get full text

Consensus statement on the clinical management of human immunodeficiency virus-associated neurocognitive disorders by Podzamczer Palter, Daniel, Muñoz-Moreno, José A, Alcolea Rodríguez, Daniel, Alonso Villaverde, Carlos, Antela López, Antonio, Blanch Andreu, Jordi, Casado Osorio, José Luis, Galindo Puerto, M José, Garolera i Freixa, Maite, Locutura Rupérez, Jaime, Lleó Bisa, Albert, Prats París, Anna, Pérez-Valero, Ignacio, Portilla Sogorb, Joaquín, Rovira Cañellas, Alex, Téllez Molina, M Jesús, Tiraboschi, Juan Manuel, Vergara Moragues, Esperanza, Arribas López, José Ramón, Goenaga Sánchez, Miguel Ángel, de León-Naranjo, Fernando Lozano, Martínez Chamorro, Esteban, Polo Rodríguez, Rosa, Podzamczer, Daniel

“…To develop a consensus document containing clinical recommendations for the management of human immunodeficiency virus (HIV)-associated neurocognitive disorder…”
Get more information

Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone by Muñoz de Benito, Rosa María, Arribas López, Jose Ramón

“…Truvada is the coformulation of tenofovir disoproxil fumarate (TDF; 300 mg) and emtricitabine (FTC; 200 mg) in a single tablet, providing the nucleotide…”
Get more information